Skip to main content

Your search for “CIRM” returned 65 results

Scientists Receive $4.8M to Pursue Gene Therapy for ‘Incurable’ Disease

December 1, 2022

The California Institute for Regenerative Medicine has awarded UC San Diego researchers $4.8 million to advance a gene therapy to treat Friedreich’s ataxia, a rare but devastating neuromuscular disorder.

UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials

November 21, 2022

UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.

UC San Diego Researcher Funded for Stem-Cell-based Preeclampsia Therapies

December 12, 2012

Dr. Mana Parast, an assistant professor of pathology at the University of California, San Diego School of Medicine, has been awarded a $3 million grant to continue her research into new therapies for preeclampsia, a pregnancy complication that often results in additional neonatal complications.

Two UC San Diego Scientists Receive Stem Cell Technology Grants

February 2, 2015

The governing board of the California Institute for Regenerative Medicine (CIRM) has awarded two University of California, San Diego researchers almost $3 million in combined funding to pursue new technologies intended to accelerate advances moving stem cell therapies out of the lab and into the clinic.

State’s Stem Cell Agency Awards Nearly $8 Million for New Leukemia Therapies

December 1, 2017

The Independent Citizens Oversight Committee of the California Institute for Regenerative Medicine (CIRM) unanimously approved yesterday two grants worth a total of almost $8 million to University of California San Diego School of Medicine researchers investigating novel stem cell-based treatments for acute myeloid leukemia or AML.

UC San Diego Cancer Researchers Receive $4 Million CIRM Disease-Team Grant

December 13, 2013

Researcher Thomas J. Kipps, MD, PhD, professor of medicine and deputy director of research operations at UC San Diego Moores Cancer Center, is principal investigator for one of six “Disease Team” awards approved December 12 by the governing board of the California Institute for Regenerative Medicine (CIRM).

UC San Diego Researchers Receive Funding to Pursue Novel Stem Cell-based Treatments

July 20, 2018

…governing board of the California Institute for Regenerative Medicine (CIRM) unanimously approved this week two grants worth more than $2.2 million to University of California San Diego School of Medicine researchers investigating stem cell-based therapies for a rare genetic disorder that affects the heart and a chronic, progressive affliction of…

State Stem Cell Agency Funds Three New UC San Diego Projects

August 25, 2021

The California Institute for Regenerative Medicine has approved a trio of awards, totaling approximately $4 million, to UC San Diego School of Medicine researchers to advance studies of new stem cell-based treatments for multiple types of cancer and amyotrophic lateral sclerosis.

Three UC San Diego Researchers Receive New CIRM Grants

March 19, 2013

Researchers at the University of California, San Diego School of Medicine are principal investigators in two of nine new grants approved today by the governing board of the California Institute for Regenerative Medicine (CIRM).

UC San Diego Research Funded By CIRM to Identify Potential Autism Drug Targets

August 28, 2013

A researcher at the University of California, San Diego School of Medicine is among principal investigators at 10 California institutions receiving Early Translational IV Research grants, totaling $40 million, approved today by the governing board of the California Institute for Regenerative Medicine (CIRM) at its meeting in San Diego.

Category navigation with Social links